Ames D

References (7)

Title : Potentially Inappropriate Medications and Anticholinergic Burden in Older People Attending Memory Clinics in Australia - Cross_2016_Drugs.Aging_33_37
Author(s) : Cross AJ , George J , Woodward MC , Ames D , Brodaty H , Ilomaki J , Elliott RA
Ref : Drugs & Aging , 33 :37 , 2016
Abstract : Cross_2016_Drugs.Aging_33_37
ESTHER : Cross_2016_Drugs.Aging_33_37
PubMedSearch : Cross_2016_Drugs.Aging_33_37
PubMedID: 26645294

Title : Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing - Sona_2012_Int.Psychogeriatr_24_197
Author(s) : Sona A , Zhang P , Ames D , Bush AI , Lautenschlager NT , Martins RN , Masters CL , Rowe CC , Szoeke C , Taddei K , Ellis KA
Ref : Int Psychogeriatr , 24 :197 , 2012
Abstract : Sona_2012_Int.Psychogeriatr_24_197
ESTHER : Sona_2012_Int.Psychogeriatr_24_197
PubMedSearch : Sona_2012_Int.Psychogeriatr_24_197
PubMedID: 21749739

Title : Negative argument for debate with V. O. Emery for J Neural Transmission : Alzheimer's disease: are we intervening too late? No we are not. Con - Ames_2011_J.Neural.Transm.(Vienna)_118_1379
Author(s) : Ames D
Ref : J Neural Transm (Vienna) , 118 :1379 , 2011
Abstract : Ames_2011_J.Neural.Transm.(Vienna)_118_1379
ESTHER : Ames_2011_J.Neural.Transm.(Vienna)_118_1379
PubMedSearch : Ames_2011_J.Neural.Transm.(Vienna)_118_1379
PubMedID: 21739113

Title : Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial - Lannfelt_2008_Lancet.Neurol_7_779
Author(s) : Lannfelt L , Blennow K , Zetterberg H , Batsman S , Ames D , Harrison J , Masters CL , Targum S , Bush AI , Murdoch R , Wilson J , Ritchie CW
Ref : Lancet Neurol , 7 :779 , 2008
Abstract : Lannfelt_2008_Lancet.Neurol_7_779
ESTHER : Lannfelt_2008_Lancet.Neurol_7_779
PubMedSearch : Lannfelt_2008_Lancet.Neurol_7_779
PubMedID: 18672400

Title : For debate: is the evidence for the efficacy of cholinesterase inhibitors in the symptomatic treatment of Alzheimer's disease convincing or not? -
Author(s) : Ames D , Kaduszkiewicz H , van den Bussche H , Zimmermann T , Birks J , Ashby D
Ref : Int Psychogeriatr , 20 :259 , 2008
PubMedID: 18252031

Title : Pharmacological treatment of cognitive deficits in Alzheimer's disease - Brodaty_2001_Med.J.Aust_175_324
Author(s) : Brodaty H , Ames D , Boundy KL , Hecker J , Snowdon J , Storey E , Yates MW
Ref : Med J Aust , 175 :324 , 2001
Abstract : Brodaty_2001_Med.J.Aust_175_324
ESTHER : Brodaty_2001_Med.J.Aust_175_324
PubMedSearch : Brodaty_2001_Med.J.Aust_175_324
PubMedID: 11665948

Title : Tacrine in Alzheimer's disease -
Author(s) : Davies B , Andrewes D , Stargatt R , Ames D , Tuckwell V , Davis S
Ref : Lancet , 2 :163 , 1989
PubMedID: 2567933